Veteran investor and operating executive with experience in private equity, M&A and corporate strategy across healthcare and business services. Steven Albrecht leads deal sourcing, operational improvement and portfolio company governance with a focus on EBITDA expansion and revenue growth initiatives. Prior roles span buyouts, corporate development and board service; education combines finance and management training. Market profile: active in mid‑market control and growth equity transactions.
Veteran investor and operating executive with experience in private equity, M&A and corporate strategy across healthcare and business services. Steven Albrecht leads deal sourcing, operational improvement and portfolio company governance with a focus on EBITDA expansion and revenue growth initiatives. Prior roles span buyouts, corporate development and board service; education combines finance and management training. Market profile: active in mid‑market control and growth equity transactions.
Focuses on control and growth equity in healthcare and business services, targeting mid‑market companies where operational levers can accelerate EBITDA and revenue. Employs a value‑creation approach that pairs disciplined buyout underwriting with hands‑on portfolio governance, prioritizing recurring revenue, margin expansion and scalable commercial initiatives. Capital allocation favors majority or substantial minority stakes with multi‑year horizons, staged capital deployment tied to operational milestones, and conservative leverage. Decision‑making blends quantitative cash‑flow analysis with operational KPIs and executive alignment to de‑risk exits.
Focuses on control and growth equity in healthcare and business services, targeting mid‑market companies where operational levers can accelerate EBITDA and revenue. Employs a value‑creation approach that pairs disciplined buyout underwriting with hands‑on portfolio governance, prioritizing recurring revenue, margin expansion and scalable commercial initiatives. Capital allocation favors majority or substantial minority stakes with multi‑year horizons, staged capital deployment tied to operational milestones, and conservative leverage. Decision‑making blends quantitative cash‑flow analysis with operational KPIs and executive alignment to de‑risk exits.
| Trades 830 | Longs Won 557/830 67% | Profit Factor 10.48 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $190,937.04 |
| Average Win $72,182.54 | Best Trade (Aug 13) $3.84M | Sharpe Ratio -10.52 |
| Average Loss -$14,057.49 | Worst Trade (Sep 30) -$606,939.63 | Z-Score 7.56 (100%) |
| Commissions $0 | Avg. Trade Length 11m 6d | Expectancy $43,826.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,634 | 6,870 | 6,107 | 5,344 | 4,580 | 3,817 | 3,053 | 2,290 | 1,527 | 763 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAP Advance Auto Parts Inc. | 85 | $3,333 | $4,720.9 | - | $1,387.9 | 41.64% | -1.157% |
AAPL Apple Inc. | 2,168 | $444,808.56 | $669,716.88 | - | $224,908.32 | 50.56% | -7.354% |
ABBV AbbVie Inc. | 5,380 | $1.18M | $1.35M | - | $168,502.72 | 14.26% | -2.513% |
ABT Abbott Laboratories | 1,635 | $216,882.83 | $172,819.5 | - | -$44,063.33 | -20.32% | +0.085% |
ADI Analog Devices, Inc. | 2,054 | $415,569.3 | $754,660.14 | - | $339,090.84 | 81.6% | +0.202% |
ADM Archer-Daniels-Midland Co | 2,615 | $187,616.01 | $207,291.05 | - | $19,675.04 | 10.49% | -1.662% |
ADP Automatic Data Processing Inc. | 420 | $128,322.53 | $111,913.2 | - | -$16,409.33 | -12.79% | +0.982% |
AEP American Electric Power Company, Inc. | 50 | $5,464 | $6,392.5 | - | $928.5 | 16.99% | +0.055% |
AFL Aflac Inc. | 5,028 | $552,551.39 | $640,969.44 | - | $88,418.05 | 16% | +0.094% |
AIG American International Group Inc. | 1,940 | $168,663.8 | $152,445.2 | - | -$16,218.6 | -9.62% | -0.393% |
ALL Allstate Corporation | 862 | $178,494.6 | $227,636.95 | - | $49,142.35 | 27.53% | -0.49% |
AMAT Applied Materials, Inc. | 14,756 | $2.97M | $7.49M | - | $4.52M | 152.14% | +1.176% |
AMGN Amgen Inc. | 3,403 | $1.04M | $1.31M | - | $270,887.61 | 26.05% | -0.64% |
AMN Amn Healthcare Services Inc. | 424 | $10,371.02 | $14,259.12 | - | $3,888.1 | 37.49% | -3.111% |
AMT American Tower Corporation | 205 | $44,608 | $35,538.8 | - | -$9,069.2 | -20.33% | -0.631% |
AMZN Amazon.com Inc | 1,740 | $334,569.43 | $472,549.18 | - | $137,979.75 | 41.24% | +15.321% |
AN AutoNation Inc. | 220 | $35,622 | $46,728 | - | $11,106 | 31.18% | -1.048% |
APH Amphenol Corporation | 16,672 | $546,758.24 | $1.34M | - | $792,836.96 | 145.01% | +0.551% |
ARCB ArcBest Corporation | 655 | $46,181.11 | $94,549.26 | - | $48,368.15 | 104.74% | +1.605% |
ARCC Ares Capital Corporation | 763 | $16,696.07 | $14,313.88 | - | -$2,382.19 | -14.27% | -0.372% |